Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Infection Reactivation”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Early research (Phase 1)Looking for participantsNCT05183490
What this trial is testing

R-MVST Cells for Treatment of Viral Infections

Who this might be right for
Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more
Columbia University 36
Not applicableActive Not RecruitingNCT04916704
What this trial is testing

Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis
University Hospital Birmingham NHS Foundation Trust 70
Not applicableEnded earlyNCT02843880
What this trial is testing

Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study

Who this might be right for
CMV Infection
AdministrateurDRC 1
Not applicableLooking for participantsNCT06441669
What this trial is testing

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Who this might be right for
Cytomegalovirus Infection Reactivation
Anhui Provincial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Not applicableStudy completedNCT00467532
What this trial is testing

Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients

Who this might be right for
BurnsCytomegalovirus
University of North Carolina, Chapel Hill 60
Not applicableStudy completedNCT00006314
What this trial is testing

Cytomegalovirus Spread and Reactivation in Blood Cells

Who this might be right for
Blood DiseaseCytomegalovirus Infections
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT03067155
What this trial is testing

CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.

Who this might be right for
Hematological MalignanciesCMV Infection
University Hospital, Ghent 1
Not applicableStudy completedNCT05419206
What this trial is testing

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients

Who this might be right for
COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
Ramazan Gozukucuk 167
Early research (Phase 1)UnknownNCT03576014
What this trial is testing

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18
Testing effectiveness (Phase 2)Study completedNCT01252017
What this trial is testing

Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07225972
What this trial is testing

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Who this might be right for
CMVAdV InfectionAdV Reactivation+2 more
New York Medical College 69
Testing effectiveness (Phase 2)Looking for participantsNCT06453460
What this trial is testing

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Who this might be right for
CMVAllogeneic Stem Cell Transplantation
University of California, Irvine 50
Not applicableLooking for participantsNCT06812598
What this trial is testing

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Who this might be right for
Cytomegalovirus InfectionsCMV
The First Affiliated Hospital of Soochow University 330
Not applicableLooking for participantsNCT04030676
What this trial is testing

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Who this might be right for
Cytomegalovirus Infections
Centre Hospitalier Universitaire de Saint Etienne 196
Not applicableUnknownNCT03210090
What this trial is testing

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients

Who this might be right for
Cytomegalovirus InfectionHSCT
Maimónides Biomedical Research Institute of Córdoba 100
Testing effectiveness (Phase 2)Looking for participantsNCT02532452
What this trial is testing

Third Party Viral Specific T-cells (VSTs)

Who this might be right for
Viral InfectionViral ReactivationInfection in an Immunocompromised Host
Children's Hospital Medical Center, Cincinnati 750
Large-scale testing (Phase 3)Study completedNCT00330018
What this trial is testing

Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT)

Who this might be right for
Bone Marrow TransplantationCytomegalovirus
Hadassah Medical Organization 40
Load More Results